Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis Mammakarzinomrisiko - Genetik und molekulare Mechanismen der Pathogenese

Several advancements over the last decade have triggered the developments in the field of breast cancer risk research. One of them is the availabil- 1 Affiliations The affiliations are listed at the end of the article. " breast cancer risk l " genetic risk factors l " prediction models l " gene-environment

[1]  Yoonjung Kim,et al.  Spectrum of EGFR Gene Copy Number Changes and KRAS Gene Mutation Status in Korean Triple Negative Breast Cancer Patients , 2013, PloS one.

[2]  M. Bryś,et al.  RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women. , 2013, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[3]  Wei Lu,et al.  Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. , 2013, American journal of human genetics.

[4]  S. Rodenhuis,et al.  Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers , 2013, British Journal of Cancer.

[5]  C. Vachon,et al.  Genetic susceptibility to triple-negative breast cancer. , 2013, Cancer research.

[6]  Sebastian M. Armasu,et al.  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer , 2013, Nature Genetics.

[7]  Jaana M. Hartikainen,et al.  Large-scale genotyping identifies 41 new loci associated with breast cancer risk , 2013, Nature Genetics.

[8]  Patrick Neven,et al.  Genome-wide association studies identify four ER negative–specific breast cancer risk loci , 2013, Nature Genetics.

[9]  R. Sijmons,et al.  Prevalence of BRCA1 and BRCA2 Germline Mutations in Breast Cancer Women of Multiple Ethnic Region in Northwest China , 2013, Journal of breast cancer.

[10]  Patrick Neven,et al.  Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors , 2013, PLoS genetics.

[11]  W. Chung,et al.  Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk , 2013, PLoS genetics.

[12]  Jane E. Carpenter,et al.  A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. , 2012, Human molecular genetics.

[13]  M. Lux,et al.  Association of mammographic density with hormone receptors in invasive breast cancers: Results from a case‐only study , 2012, International journal of cancer.

[14]  Jaana M. Hartikainen,et al.  The role of genetic breast cancer susceptibility variants as prognostic factors. , 2012, Human molecular genetics.

[15]  P. Fasching,et al.  Biomarkers in Breast Cancer - An Update. , 2012, Geburtshilfe und Frauenheilkunde.

[16]  E. Ziv,et al.  CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. , 2012, Cancer discovery.

[17]  M. Lux,et al.  Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer , 2012, Breast Cancer Research and Treatment.

[18]  P. Fasching,et al.  Breast Cancer 2012 - New Aspects. , 2012, Geburtshilfe und Frauenheilkunde.

[19]  R. Wenstrup,et al.  Prevalence of BRCA mutations in an unselected population of triple‐negative breast cancer , 2012, Cancer.

[20]  Daniel J. Park,et al.  19p13.1 is a triple-negative-specific breast cancer susceptibility locus. , 2012, Cancer research.

[21]  Gretchen L. Gierach,et al.  Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[22]  W. Janni,et al.  Breast Cancer: State of the Art and New Findings. , 2012, Geburtshilfe und Frauenheilkunde.

[23]  K. Czene,et al.  Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement , 2012, Breast Cancer Research.

[24]  Michael Jones,et al.  Genome-wide association analysis identifies three new breast cancer susceptibility loci , 2012, Nature Genetics.

[25]  M. Bani,et al.  Breast Cancer Risk - Genes, Environment and Clinics. , 2011, Geburtshilfe und Frauenheilkunde.

[26]  Jane E. Carpenter,et al.  A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer , 2011, Nature Genetics.

[27]  S. Kümmel,et al.  Mammakarzinom 2011 – Neue Aspekte , 2011 .

[28]  Jane E. Carpenter,et al.  Common breast cancer susceptibility loci are associated with triple-negative breast cancer. , 2011, Cancer research.

[29]  V. Pankratz,et al.  Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. , 2011, Human molecular genetics.

[30]  Patrick Neven,et al.  Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. , 2011, Human molecular genetics.

[31]  Michael Jones,et al.  Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. , 2011, Journal of the National Cancer Institute.

[32]  Victoria L. Cafourek,et al.  Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. , 2011, Journal of the National Cancer Institute.

[33]  G. Mills,et al.  Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer , 2011, Clinical Cancer Research.

[34]  Alexander Cavallaro,et al.  Mammographic density as a risk factor for breast cancer in a German case–control study , 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[35]  A. Whittemore,et al.  Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study , 2010, Breast Cancer Research.

[36]  F. Couch,et al.  Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[37]  Christiana Kartsonaki,et al.  A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population , 2010, Nature Genetics.

[38]  Deborah Hughes,et al.  Genome-wide association study identifies five new breast cancer susceptibility loci , 2010, Nature Genetics.

[39]  M. Beckmann,et al.  Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. , 2010, Journal of the National Cancer Institute.

[40]  F. Couch,et al.  Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. , 2009, Human molecular genetics.

[41]  M. Beckmann,et al.  Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. , 2009, Journal of the National Cancer Institute.

[42]  W. Willett,et al.  A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) , 2009, Nature Genetics.

[43]  M. Thun,et al.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 , 2009, Nature Genetics.

[44]  J. Chang-Claude,et al.  Role of genetic polymorphisms and ovarian cancer susceptibility , 2009, Molecular oncology.

[45]  J. Haines,et al.  Genome-wide association study identifies a novel breast cancer susceptibility locus at 6q25.1 , 2009, Nature Genetics.

[46]  A. Sigurdsson,et al.  Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer , 2008, Nature Genetics.

[47]  Dieter Niederacher,et al.  Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2008, American journal of human genetics.

[48]  H A Risch,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions , 2008, British Journal of Cancer.

[49]  Karla Kerlikowske,et al.  Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.

[50]  F. Couch,et al.  RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. , 2007, American journal of human genetics.

[51]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.

[52]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[53]  Jaana M. Hartikainen,et al.  A common coding variant in CASP8 is associated with breast cancer risk , 2007, Nature Genetics.

[54]  N. Boyd,et al.  Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.

[55]  M. Bani,et al.  Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics. , 2006, European journal of radiology.

[56]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[57]  D. Easton,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancer , 2004, British Journal of Cancer.

[58]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[59]  J. Stephenson.  Breast Cancer Risk , 2003 .

[60]  J. Ranstam,et al.  Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease , 2002, The Lancet.

[61]  Giovanni Parmigiani,et al.  BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  Julian Peto,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.

[63]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[64]  H. Adami,et al.  Transient increase in the risk of breast cancer after giving birth. , 1994, The New England journal of medicine.

[65]  J. Benichou,et al.  Validation studies on a model for breast cancer risk. , 1994, Journal of the National Cancer Institute.

[66]  J. Benichou,et al.  Epidemiology and Biostatistics Program of the National Cancer Institute , 1994 .

[67]  N. Risch,et al.  The calculation of breast cancer risk for women with a first degree family history of ovarian cancer , 1993, Breast Cancer Research and Treatment.

[68]  Phil Bidwell,et al.  Breast Cancer Risk , 2013 .

[69]  A. Antoniou,et al.  Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[70]  F. Martin,et al.  Molecular links between mammary gland development and breast cancer. , 2007, Cellular and molecular life sciences : CMLS.

[71]  D. Berry,et al.  Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.